Swiss researchers have successfully devised a method to preserve color vision in cases of inherited retinal disorders and age-related macular degeneration by employing lab-grown mini-retinas. This breakthrough was detailed in the scientific periodical Neuron.
The cone cells — photoreceptors concentrated in the macula (yellow spot) — are responsible for our ability to read, recognize faces, and maintain color perception. Numerous genetic ailments lead to the loss of central vision. Until now, effective therapeutic approaches have been absent, despite decades of ongoing investigation in this field.
A team led by personnel from the Swiss Institute of Molecular and Clinical Ophthalmology in Basel utilized twenty thousand laboratory-cultivated mini-retinas (human retinal organoids). These three-dimensional structures mimic the core characteristics of genuine retinal tissue, allowing for compound testing under conditions closely mirroring reality.
Cones within the organoids were selectively tagged, enabling researchers to monitor their fate when subjected to artificial stress simulating disease states. The investigators screened over 2,700 compounds known to have specific molecular targets.
The screening process revealed distinct patterns. Two categories of kinase inhibitors consistently offered prolonged protection to the cone cells. The essential protective mechanism involves the suppression of the protein kinase CK1 (casein kinase 1). This protective influence was substantiated across various stress models, including an in vivo mouse model of retinal degeneration.
However, several compounds were observed to conversely harm the cones. This finding furnishes crucial intelligence regarding potential toxicological hazards for future therapeutic development.
Furthermore, the study’s authors have made the complete dataset detailing the research findings publicly accessible, which should aid their colleagues in subsequent investigations.
About the Author
